ROCKLAND, Mass. & SAN DIEGO--(BUSINESS WIRE)--EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt Germany, today introduced the 6th edition of the EMD Serono Specialty Digest™ at the 22nd Annual Meeting of the AMCP in San Diego, CA. The EMD Serono Specialty Digest™, previously known as the EMD Serono Injectables Digest™, was renamed to reflect the current trend towards oral therapies within the specialty pharmaceutical arena. The Digest is provided as an educational resource to improve the understanding of trends and considerations in the management of specialty therapeutics; create a dialogue around patient access to therapy; and improve patient outcomes while ensuring appropriate management.
